Leaders from the Field of Pain Therapeutics to Discuss Latest Discoveries and Breakthroughs at Arrowhead's 3rd Annual Pain Therapeutics Summit

Leaders from the Field of Pain Therapeutics to Discuss Latest Discoveries and Breakthroughs at Arrowhead's 3rd Annual Pain Therapeutics Summit

Arrowhead's 3rd Annual Pain Therapeutics Summit, scheduled to take place in Summit, NJ on September 24th and September 25th, 2009, will be bringing together leaders in pain therapeutics and management to discuss the latest developments in discovery research, preclinical development, clinical development, regulatory issues and real-world pain management in the clinic.

Minneapolis, MN (PRWEB) -- Arrowhead's 3rd Annual Pain Therapeutics Summit (http://www.arrowheadpublishers.com/conferences/pain-therapeutics-2009/#_overview), scheduled to take place in Summit, NJ on September 24th and September 25th, 2009, will be bringing together leaders in pain therapeutics and management to discuss the latest developments in discovery research, preclinical development, clinical development, regulatory issues and real-world pain management in the clinic.

Arrowhead's Annual Pain Therapeutics Summit (http://www.arrowheadpublishers.com/conferences/pain-therapeutics-2009/#_overview) is the US's premier conference covering the field of pain management and therapeutics. Leaders from the pharmaceutical, biotech, device and medical communities attend this conference to learn about the latest advances in the treatment of various types of pain and to network with colleagues from industry, academia, the medical community, government and investors.

This year's presentations will highlight the most important developments in recent years in the field, including new research in sodium channel blockers (TRPV1 and TRPA1), late-stage clinical advances with Merck's CGRP antagonist program, new research in biologic therapies, the genetics of pain, abuse-resistant opioids, analysis of FDA's REMS program and a plethora of other topics.

This year's summit will feature presentations from the nation's foremost pain experts: including, (but not limited to):

* Frank Porreca, Ph.D., (Chair) Professor, Department of Pharmacology & Anesthesiology, College of Medicine, University of Arizona

* Daniel B. Carr, MD, Chief Medical Officer & President, Javelin Pharmaceuticals

* Lynn R. Webster, MD, FACPM, FASAM, Medical Director and Founder, Lifetree Clinical Research & Pain Clinic, Director-At-Large, American Academy of Pain Medicine

* Theodore J. Cicero, Ph.D., Professor, Departments of Psychiatry and Anatomy and Neurobiology, Washington University in St. Louis

* Tony Ho, Senior Director Clinical Neuroscience, Merck Research Laboratories

* Tarek Samad, Ph.D., Head, Pain Molecular Neurobiology, Neuroscience Discovery, Wyeth Research

* Jeffrey Tobias, MD, Chief Medical Officer, NeurogesX, Inc.

* Mila Etropolski, MD, Sr. Director, Clinical Leader, Clinical Research and Development, CNS/Pain TA, Johnson and Johnson

* John S. Andrews, Ph.D., President, Head of R&D, NeurAxon

* Joseph W. Stauffer, DO, Principal, Alta Life Sciences LLC, Adjunct Assistant Professor, Johns Hopkins University School of Medicine, Department of Anesthesiology & Critical Care Medicine, Division of Pain Medicine, formerly Chief Medical Officer, Senior Vice President Clinical Research & Medical Affairs, Alpharma Inc.

For more information about this conference, please visit www.arrowheadpublishers.com, or call 1-312-244-3703, ext. 4.

###

Contact Information SALES DEPT

Arrowhead Publishers and Conferences

http://www.arrowheadpublishers.com

1-312-244-3703